Literature DB >> 9032337

Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo.

M S McBride1, A T Panganiban.   

Abstract

At least two hairpins in the 5' untranslated leader region, stem-loops 1 and 3 (SL1 and SL3), contribute to human immunodeficiency virus type 1 RNA encapsidation in vivo. We used a competitive assay, which measures the relative encapsidation efficiency of mutant viral RNA in the presence of competing wild-type RNA, to compare the contributions of SL1, SL3, and two adjacent secondary structures, SL2 and SL4, to encapsidation. SL2 is not required for RNA encapsidation, while SL1, SL3, and SL4 all contribute approximately equally to encapsidation. To determine whether these hairpins function in a position-dependent manner, we interchanged the positions of two of these stem-loop structures. This resulted in substantial diminution of encapsidation, indicating that the secondary structures that comprise E, the encapsidation signal, function only in their correct contexts. Mutation of nucleotides flanking SL1 and SL3 had little effect on encapsidation. We also showed that SL1, while present on both genomic and subgenomic viral RNAs, nonetheless contributes to selective encapsidation of genomic RNA. Taken together, these data are consistent with the formation of a higher-order RNA structure, partially composed of SL1, SL3, and SL4, that functions to effect concurrent encapsidation of full-length RNA and exclusion of subgenomic RNA. Finally, it has been reported that E is required for efficient translation of Gag mRNA in vivo. However, we have found that a variety of mutants, including a mutant lacking the entire region encompassing SL1, SL2, and SL3, still produce RNAs that are efficiently translated. These data indicate that E is unlikely to contribute to efficient Gag mRNA translation in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032337      PMCID: PMC191293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.

Authors:  A Garzino-Demo; R C Gallo; S K Arya
Journal:  Hum Gene Ther       Date:  1995-02       Impact factor: 5.695

2.  Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA.

Authors:  J C Paillart; R Marquet; E Skripkin; B Ehresmann; C Ehresmann
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

3.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro.

Authors:  E Skripkin; J C Paillart; R Marquet; B Ehresmann; C Ehresmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide.

Authors:  D Muriaux; P M Girard; B Bonnet-Mathonière; J Paoletti
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

6.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.

Authors:  R Marquet; J C Paillart; E Skripkin; C Ehresmann; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

7.  A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA.

Authors:  M Laughrea; L Jetté
Journal:  Biochemistry       Date:  1994-11-15       Impact factor: 3.162

8.  Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor.

Authors:  S Vagner; A Waysbort; M Marenda; M C Gensac; F Amalric; A C Prats
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

9.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors.

Authors:  C Berlioz; J L Darlix
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  69 in total

1.  Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Authors:  F Jossinet; J C Paillart; E Westhof; T Hermann; E Skripkin; J S Lodmell; C Ehresmann; B Ehresmann; R Marquet
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

5.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.

Authors:  Rodney S Russell; Jing Hu; Véronique Bériault; Andrew J Mouland; Michael Laughrea; Lawrence Kleiman; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Rapid purification of RNA secondary structures.

Authors:  Stacy L Gelhaus; William R LaCourse; Nathan A Hagan; Gaya K Amarasinghe; Daniele Fabris
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

9.  In vitro characterization of a base pairing interaction between the primer binding site and the minimal packaging signal of avian leukosis virus genomic RNA.

Authors:  Igor Kanevsky; Natalya Vasilenko; Hélène Dumay-Odelot; Philippe Fossé
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

10.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.